Overview
Nicholas Paul Campbell, MD, an oncologist at Endeavor Health, focuses on the treatment of lung cancer and cancers of the head and neck. With 16 years of experience, he cares for patients facing complex diagnoses such as esophagus, oropharyngeal and laryngeal cancers. Dr. Campbell develops individualized treatment plans tailored to each patient’s condition, including those with rare malignancies like Merkel cell carcinoma and basal cell cancer.
Dr. Campbell is rated as a Distinguished provider by MediFind in the treatment of EGFR Positive Lung Cancer. His top areas of expertise are Lung Cancer, Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), and EGFR Positive Lung Cancer.
His clinical research consists of co-authoring 12 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has participated in 1 clinical trial in the study of EGFR Positive Lung Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- INSURANCE PLAN
- MEDICARE MAPD
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE PDP
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2650 Ridge Ave., Kellogg Cancer Center, Evanston, IL 60201
757 Park Ave. West, Kellogg Cancer Center, Highland Park, IL 60035
5140 N. California Ave., Suite 600-GMP, Chicago, IL 60625
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
10 Clinical Trials
Philip Bonomi is an Oncologist in Chicago, Illinois. Dr. Bonomi is rated as an Elite provider by MediFind in the treatment of EGFR Positive Lung Cancer. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, and Small Cell Lung Cancer (SCLC).
Young Chae is a Hematologist and an Oncologist in Chicago, Illinois. Dr. Chae has been practicing medicine for over 24 years and is rated as an Elite provider by MediFind in the treatment of EGFR Positive Lung Cancer. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), and Tissue Biopsy.
Endeavor Health Medical Group
Thomas Hensing is an Oncologist in Glenview, Illinois. Dr. Hensing is rated as a Distinguished provider by MediFind in the treatment of EGFR Positive Lung Cancer. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and EGFR Positive Lung Cancer. Dr. Hensing is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acinic Cell Carcinoma of Salivary GlandsDr. Campbell isDistinguished. Learn about Acinic Cell Carcinoma of Salivary Glands.
- ALK-Positive Non-Small Cell Lung CancerDr. Campbell isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- EGFR Positive Lung CancerDr. Campbell isDistinguished. Learn about EGFR Positive Lung Cancer.
- Epithelial-Myoepithelial CarcinomaDr. Campbell isDistinguished. Learn about Epithelial-Myoepithelial Carcinoma.
- Large-Cell Lung CarcinomaDr. Campbell isDistinguished. Learn about Large-Cell Lung Carcinoma.
- Laryngeal CancerDr. Campbell isDistinguished. Learn about Laryngeal Cancer.
- Advanced
- Adenoid Cystic CarcinomaDr. Campbell isAdvanced. Learn about Adenoid Cystic Carcinoma.
- Bone TumorDr. Campbell isAdvanced. Learn about Bone Tumor.
- Ewing SarcomaDr. Campbell isAdvanced. Learn about Ewing Sarcoma.
- Fibrolamellar CarcinomaDr. Campbell isAdvanced. Learn about Fibrolamellar Carcinoma.
- GliomaDr. Campbell isAdvanced. Learn about Glioma.
- Lymphofollicular HyperplasiaDr. Campbell isAdvanced. Learn about Lymphofollicular Hyperplasia.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Campbell isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with MaturationDr. Campbell isExperienced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Campbell isExperienced. Learn about Acute Myeloid Leukemia (AML).
- AgranulocytosisDr. Campbell isExperienced. Learn about Agranulocytosis.
- Anal CancerDr. Campbell isExperienced. Learn about Anal Cancer.